sequencing
(2)
Tom Willis
Tom Willis, PhD, is a genomics entrepreneur with more than 20 years of company-building experience who became CEO of Arima Genomics in June 2025. A Yale and Stanford physicist turned biotech serial founder, he co-invented Molecular Inversion Probe technology, built two genomics companies from the ground up - ParAllele BioScience (acquired by Affymetrix) and Sequenta (whose ClonoSEQ assay became NCCN-standard for leukemia and lymphoma residual disease testing) - then spent a decade as Venture Partner at Illumina Ventures before stepping in to lead Arima, a company pioneering 3D genomics for cancer diagnostics.
Florin Tatulea
Florin Tatulea is a Toronto-based sales development leader, founder, and creator who built a 74,000+ follower LinkedIn audience by teaching SDRs and AEs how to actually hit quota. Currently Head of Sales Development at Common Room and GTM Engineer in Residence at ZoomInfo, he founded Sales Flo to run workshops and training for reps at Shopify, Zendesk, Clearbit, and others. His Substack newsletter 'Prospecting from the Trenches' reaches 12,000+ subscribers with tactical cold email and prospecting advice drawn from real-world experience scaling teams and generating $3M in pipeline.